AVAX Technologies, Inc. (AVXT)
AVXT Stock Price Chart
Explore AVAX Technologies, Inc. interactive price chart. Choose custom timeframes to analyze AVXT price movements and trends.
AVXT Company Profile
Discover essential business fundamentals and corporate details for AVAX Technologies, Inc. (AVXT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 May 1997
Employees
9.00
Website
https://www.avax-tech.comCEO
Adele Sommerfeld
Description
AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. The company's product candidates that have completed phase II clinical trials include M-VAX for the treatment of melanoma and O-VAX for the treatment for ovarian cancer. It also develops LungVax for the treatment of non-small cell lung cancer. The company was formerly known as Walden Laboratories, Inc. and changed its name to AVAX Technologies, Inc. in March 1996. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.
AVXT Financial Timeline
Browse a chronological timeline of AVAX Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
AVXT Stock Performance
Access detailed AVXT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.